These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31569785)

  • 1. Advances in RNA Vaccines for Preventive Indications: A Case Study of A Vaccine Against Rabies.
    Armbruster N; Jasny E; Petsch B
    Vaccines (Basel); 2019 Sep; 7(4):. PubMed ID: 31569785
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial.
    Alberer M; Gnad-Vogt U; Hong HS; Mehr KT; Backert L; Finak G; Gottardo R; Bica MA; Garofano A; Koch SD; Fotin-Mleczek M; Hoerr I; Clemens R; von Sonnenburg F
    Lancet; 2017 Sep; 390(10101):1511-1520. PubMed ID: 28754494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs.
    Schnee M; Vogel AB; Voss D; Petsch B; Baumhof P; Kramps T; Stitz L
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004746. PubMed ID: 27336830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.
    Koraka P; Bosch BJ; Cox M; Chubet R; Amerongen Gv; Lövgren-Bengtsson K; Martina BE; Roose J; Rottier PJ; Osterhaus AD
    Vaccine; 2014 Aug; 32(36):4644-50. PubMed ID: 24962755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial.
    Aldrich C; Leroux-Roels I; Huang KB; Bica MA; Loeliger E; Schoenborn-Kellenberger O; Walz L; Leroux-Roels G; von Sonnenburg F; Oostvogels L
    Vaccine; 2021 Feb; 39(8):1310-1318. PubMed ID: 33487468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APRIL:TACI axis is dispensable for the immune response to rabies vaccination.
    Haley SL; Tzvetkov EP; Lytle AG; Alugupalli KR; Plummer JR; McGettigan JP
    Antiviral Res; 2017 Aug; 144():130-137. PubMed ID: 28619678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis.
    Haley SL; Tzvetkov EP; Meuwissen S; Plummer JR; McGettigan JP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
    Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A thermostable messenger RNA based vaccine against rabies.
    Stitz L; Vogel A; Schnee M; Voss D; Rauch S; Mutzke T; Ketterer T; Kramps T; Petsch B
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006108. PubMed ID: 29216187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection.
    Galvez-Romero G; Salas-Rojas M; Pompa-Mera EN; Chávez-Rueda K; Aguilar-Setién Á
    Vaccine; 2018 Jan; 36(2):292-298. PubMed ID: 29191739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
    Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in rabies vaccination.
    Fisher CR; Schnell MJ
    Rev Sci Tech; 2018 Aug; 37(2):657-672. PubMed ID: 30747119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens.
    da Fontoura Budaszewski R; Hudacek A; Sawatsky B; Krämer B; Yin X; Schnell MJ; von Messling V
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
    Koprowski H
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Interleukin-7 Extends the Humoral Immune Response Induced by Rabies Vaccination.
    Li Y; Zhou M; Luo Z; Zhang Y; Cui M; Chen H; Fu ZF; Zhao L
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
    Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
    Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA immunization protects nonhuman primates against rabies virus.
    Lodmell DL; Ray NB; Parnell MJ; Ewalt LC; Hanlon CA; Shaddock JH; Sanderlin DS; Rupprecht CE
    Nat Med; 1998 Aug; 4(8):949-52. PubMed ID: 9701249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
    Giel-Moloney M; Rumyantsev AA; David F; Figueiredo M; Feilmeier B; Mebatsion T; Parrington M; Kleanthous H; Pugachev KV
    Vaccine; 2017 Dec; 35(49 Pt B):6898-6904. PubMed ID: 28899628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
    Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.